Abstract
Objectives: We evaluated the effect of thalidomide and apatinib in prevention of camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have